Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1478 (LINC01478) is a human lincRNA, a subclass of long non-coding RNAs, defined by autonomous transcription from intergenic genomic regions and lacking protein-coding potential. LincRNAs broadly tune gene expression, influence chromatin architecture, act in post-transcriptional regulation, and can serve as disease biomarkers or therapeutic targets. LINC01478 itself is currently poorly studied, with only hypothetical associations to cancer and no known functions, disease roles, interacting drugs, or validated biomarkers.
For LINC01478 specifically, none are reported. For lincRNAs in general, mechanisms when targeted include post-transcriptional degradation or silencing by antisense pairing, and modulation of their regulatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1478 (LINC01478).